Orchestra BioMed Holdings, Inc.Orchestra BioMed Holdings, Inc.Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc.

No trades
See on Supercharts

OBIO fundamentals

An in-depth look to Orchestra BioMed Holdings, Inc. operating, investing, and financing activities

OBIO free cash flow for Q4 24 is -13.64 M USD. For 2024, OBIO free cash flow was -50.85 M USD and operating cash flow was -50.56 M USD.

Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM
Free cash flowYoY growth